Esophageal carcinoma Esophageal carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who treated with neoadjuvant chemotherapy followed by esophagectomy for esophageal carcinoma. 2. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. oral feeding difficulty. 2. Treated with enteral nutrition other than ENORAS liquid for enteral use. 3. History of treatment for esophageal carcinoma. 4. Planed to undergo two-stage operation. 5. Contraindicate for ENORAS liquid for enteral use. 6. Ineligible for the study at the physician's assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The factors mentioned below will be evaluated comparing with historical controls. perioperative nutrition indexes GPS: Glasgow Prognostic Score mGPS: modified GPS PNI: Prognostic Nutritional Index CONUT score: Controlling Nutritional Status Score NLR: Neutrophil Lymphocyte Ratio PLR: Platelet Lymphocyte Ratio LMR: Lymphocyte Monocyte Ratio CAR: CRP Albumin Ration Alb: Albumin CRP: C reactive Protein Ch-E: Cholinesterase T-cho: Total Cholesterol Body weight Body composition | — |
Secondary
| Measure | Time frame |
|---|---|
| The factors mentioned below will be evaluated comparing with historical controls. Postoperative pneumoniae Postoperative complications Postoperative hospital stays Oral dose of ENORAS liquid for enteral use Diarrhea | — |
Contacts
Nagoya University Hospital